Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

• Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers

  Business - MarketWatch - 2 hours ago

• Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

  Business - MarketWatch - October 24

• Hoping for a weight-loss pill? It could get closer to reality next week.

  Business - MarketWatch - November 2

• AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

  Business - MarketWatch - November 5

• Sage Therapeutics to end development of key therapy after a third trial failure

  Business - MarketWatch - 23 hours ago

• Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

  Business - CNBC - Yesterday

More from MarketWatch

• Trump’s choice of TV’s ‘Dr. Oz’ to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

  Business - MarketWatch - 13 minutes ago

• Treasury yields slip as traders weigh increased Russia-Ukraine tensions

  Business - MarketWatch - 17 minutes ago

• This Roth strategy lets elite savers stash $70,000 in their 401(k) in 2025

  Business - MarketWatch - 20 minutes ago

• After Nvidia’s earnings, this is the most impressive feat

  Business - MarketWatch - 22 minutes ago

• Retail investors are feeling unusually optimistic about the market — here’s why

  Business - MarketWatch - 24 minutes ago